Fundraising Fox

Sofie Biosciences

Culver City, US · Delaware corporation · 1 known investors

Founders & leadership

MP
Michael PhelpsFounder
SB
Stan BermanExecutive
PP
Patrick PhelpsExecutive
JC
Johannes CzerninNamed on SEC filing
JH
James HeathNamed on SEC filing

Board

AS
Ajit SinghBoard director
CW
Carl W. McKinzieBoard director
RD
Roy DoumaniBoard director
HM
Howard MaronBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$4.7M disclosed across 2 of 3 rounds · 2016–2019

$950KraisedJul 2019 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick E. PhelpsExecutive Officer, Director
  • Joel CohenExecutive Officer
  • Johannes CzerninDirector
  • Ken Hermann, M.D.Director
  • James HeathDirector
  • Michael PhelpsDirector
  • Ajit SinghDirector
  • Howard MaronDirector
  • Carl W. McKinzieDirector
  • Philipp CzerninExecutive Officer
  • Melissa Moore, Ph.DExecutive Officer
Offering amount
$950K
Amount sold
$950K
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$16.8MofferedJun 2017 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stan BermanExecutive Officer
  • Roy DoumaniDirector
  • Johannes CzerninDirector
  • Patrick E. PhelpsExecutive Officer, Director
  • Ajit SinghDirector
  • Philipp CzerninExecutive Officer
  • Michael PhelpsDirector
  • Carl W. McKinzieDirector
  • Howard MaronDirector
  • James HeathDirector
  • Melissa Moore, Ph.DExecutive Officer
Offering amount
$16.8M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.7MraisedJun 2016 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl W. McKinzieDirector
  • Michael E. PhelpsDirector
  • Johannes CzerninDirector
  • Roy DoumaniDirector
  • Stan BermanExecutive Officer
  • Patrick PhelpsExecutive Officer, Director
  • James HeathDirector
  • Howard MaronDirector
  • Ajit SinghDirector
Offering amount
$4M
Amount sold
$3.7M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 10 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$149.8K
National Institutes of Health (NIH)National Institutes of HealthPhase II2014$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$1.8M
Department of EnergyPhase II2012$995.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$250K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$145.2K
Department of EnergyPhase I2011$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Sofie Biosciences?
Sofie Biosciences was founded by Michael Phelps.
Who are Sofie Biosciences's investors?
Sofie Biosciences's investors include Cycad Group LLC.
How much funding has Sofie Biosciences raised?
Sofie Biosciences has disclosed $4.7M raised across 2 of its 3 known rounds.
Where is Sofie Biosciences headquartered?
Sofie Biosciences is headquartered in Culver City, US.